NetworkNewsBreaks Archive - Page 366 of 2163

WednesdayAug 07, 2024 10:25 am

NetworkNewsBreaks – Bebuzee Inc. (BBUZ) Announces ‘Milestone’ Launch of SuperApp Designed to Change Users’ Interaction with Digital Services

Bebuzee (OTC: BBUZ), a pioneering force in the realm of social technology, has unveiled a new SuperApp designed to transform the way users interact with technology. According to the announcement, the new app, which will be available Aug. 30, 2024, offers an extensive array of features in a single, seamless platform. Those features include video streaming, photo sharing, instant messaging, short-form videos, global real estate search and e-commerce capabilities. The company noted that the new app opens unprecedented revenue opportunities. With potential in a wide array of markets, including video ads, sponsored posts, premium subscriptions and more, the app will…

TuesdayAug 06, 2024 2:20 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Tech, PureSecurity Suite Offers Tools to Address Growing Domestic Violence Concerns

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has noted that electronic monitoring (“EM”) technology is being utilized as a significant and accessible solution for preventing domestic violence. With that in mind, the company is interested in seeing the tools in its PureSecurity Suite used to protecting victims of domestic violence; the platform can help track offenders and enforce court-issued protective orders. According to a recent article, the quality of SuperCom’s technology as well as other related services has led to an additional $11 million in new contract revenue…

TuesdayAug 06, 2024 2:03 pm

NetworkNewsBreaks – Finovate Shares FinovateFall Agenda Highlights

Finovate, a research and events company focused on innovation in financial and banking technology, is hosting FinovateFall, a pioneering fintech conference focused on the digital future of financial institutions. The event is slated for Sept. 9–11, 2024, in New York City. According to the announcement, the three-day fintech conference is “by and for executives and thought leaders who are revolutionizing the financial services industry.” The event agenda includes presentations from more than 120 renowned speakers and subject matter experts and more than 60-plus live product demonstrations from a range of fintech companies, including startups to established players. Speakers for the…

TuesdayAug 06, 2024 1:26 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases “Noteworthy” Weight-Loss Results from Recent Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting recent results from its WEIGHT-A24-1 animal study. A recent article notes that interim results, which are based on the first 28 days of dosing, are “noteworthy,” including all animals showing either a noticeable decrease in the rate of body weight gain or the beginning of weight reduction. According to the article, the study was designed to the impact of Lexaria’s patented DehydraTECH technology on glucagon-like peptide-1 (“GLP-1”) drugs for the potential treatment of diabetes and weight loss; the article noted that this study marks a “significant milestone”…

TuesdayAug 06, 2024 1:01 pm

NetworkNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Schedules Conference Call to Discuss Q2 2024 Results

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is announcing the date for its upcoming conference call and webcast. The call is slated to begin at 11 a.m. EDT on Aug. 8, 2024. During the call, management will discuss the company’s second-quarter 2024 financial results as well as project developments. The call will also include time for questions and answers, with those on the call able to ask questions directly over the phone. Those wanting to participate can dial (888) 210-3454 toll free in North American, then use conference…

TuesdayAug 06, 2024 12:48 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Submits New CNM-Au8 Biomarker, Clinical Efficacy Data to FDA

Clene (NASDAQ: CLNN), a late-stage biopharmaceutical company focused on protecting mitochondrial health and neuronal function to treat neurodegenerative diseases, and its wholly owned subsidiary Clene Nanomedicine Inc., have submitted new data to the U.S. Food and Drug Administration (“FDA”). The data is regarding CNM-Au8(R) biomarker and clinical efficacy information, including post hoc analyses from two phase 2 clinical trials of CNM-Au8 for the treatment of ALS; the trials were conducted independently. According to the announcement, this new data is in addition to original data the company has discussed with FDA and is intended to guide the planned FDA Type C interaction; that…

TuesdayAug 06, 2024 12:36 pm

NetworkNewsBreaks – Astiva Health Announces Launch of Investor Relations Website to Facilitate Transparent, Effective Communication

Astiva Health, a leader in innovative and culturally aware healthcare solutions, today announced the launch of its new Investor Relations website. The launch marks a significant step and milestone in the company’s journey towards becoming a public company. It emphasizes Astiva Health’s commitment to maintaining transparent and effective communication and building strong relationships with investors, stakeholders, and the broader financial community. The platform will offer easy access to detailed company overviews and strategic vision, financial reports and performance metrics, press releases and media coverage, corporate government practices, and upcoming events and presentations. “We are excited to launch our Investor Relations…

TuesdayAug 06, 2024 12:07 pm

NetworkNewsBreaks – Snap Inc. (NYSE: SNAP) Faces Downturn Despite Revenue Growth

Snap (NYSE: SNAP), the parent company of Snapchat, faced a significant downturn in its stock value during after-hours trading following its second-quarter earnings report for 2024. Despite a 16% year-over-year increase in total revenue, reaching $1.24 billion, the decline in the company’s stock reflects investor concerns about Snap’s future growth prospects, especially given the deceleration from the 21% growth recorded in the first quarter of 2024. The mixed financial results also highlighted a net loss of $249 million, which, despite being a 34% improvement from the previous year, still raises questions about the company’s profitability. Snap’s user engagement metrics, however, paint a more positive picture. The Daily Active…

TuesdayAug 06, 2024 11:34 am

NetworkNewsBreaks – Blockchain Futurist Conference Plays Pivotal Role in Shaping the Future of Web3, Finance

Blockchain Futurist Conference is Canada’s largest and most high-profile Web3, blockchain and cryptocurrency event. Serving as an essential platform for ideas and collaboration, the conference has proven to be an important global gathering helping shape the future of Web3. This year’s event is scheduled for August 13-14, 2024, in Toronto, Canada; the event will run alongside ETHToronto and ETHWomen Hackathons, the largest web3 hackathons in Canada. During Futurist 2023, reporter Daniel Bruno solicited quotes from onsite attendees experiencing the excitement of the event. What they said sets the tone for this year’s dynamic must-attend Blockchain Futurist Conference. “We have attended…

TuesdayAug 06, 2024 11:13 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Reports on Clinical Data Showing Lead Compound Combined with GLP-1 Agonist Enhances Cognition

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting preclinical data regarding its lead compound, buntanetap. According to the announcement, the results show the synergistic effect of buntanetap when combined with the glucagon-like peptide 1 (“GLP-1”) agonist dulaglutide (Trulicity[R]) in a mouse model of Alzheimer’s disease. Based on data gathered in 2018 showing that buntanetap fully restored memory, learning and synaptic potentiation in an Alzheimer’s mouse model, Annovis recently studied whether buntanetap combined with the GLP-1 agonist dulaglutide produced a synergistic effect in the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks